Skip to main content

Elmind Capital, LP

Location
NEW YORK, NY
Portfolio Value
Small $352,219,180
Diversification
Diversified
Filing Date
Global Rank
#2,842 / 8,232 ▲ 291
Top Industry
Biotechnology 94.0%
3Y Alpha vs SPY
-26.2%
Period ended 2 months ago
Filed May 15, 2026 · 29d
2 quarters · since Dec 2025

Clone Performance

Feb 2026–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+1.4%
SPY
+9.1%
Annualised alpha
-26.2%
Max drawdown
−14.5%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

34 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
12.8%
+0.1 pts
Top 5
44.8%
−2.5 pts
Top 10
68.8%
−2.0 pts
HHI
625
Dec 2025 → Mar 2026 · range 625 – 645
Diversified−20

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 100.0% $352,219,180

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
7 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
6 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
2 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
1 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
34 positions · $352,219,180 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History